CASEY BODKIN: Open Payments
NPI 1881306769 · DECATUR, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$738 in 43 payments from 12 companies in 2025. Trend: 2023 $0 · 2024 $342 · 2025 $738
Food & beverage: $654Education: $84
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 13 | $180 |
| Ardelyx, Inc. | 9 | $161 |
| Janssen Biotech, Inc. | 6 | $144 |
| Phathom Pharmaceuticals, Inc. | 6 | $59 |
| Ipsen Biopharmaceuticals, Inc | 2 | $46 |
| Celltrion USA Inc. | 1 | $26 |
| Gilead Sciences, Inc. | 1 | $25 |
| GENZYME CORPORATION | 1 | $23 |
| Novo Nordisk Inc | 1 | $22 |
| Janssen Scientific Affairs, LLC | 1 | $19 |
Products named: TREMFYA, IBSRELA, CREON, VOQUEZNA, RINVOQ, IQIRVO, LINZESS, VEGZELMA.
Industry payments across AL — which companies pay providers there.
